Avista Healthcare Partners acquires sanotact

Avista Healthcare Partners has entered a definitive agreement to acquire sanotact Group GmbH, a German company specializing in vitamins, minerals, and supplements (VMS), in collaboration with strategic co-investor Damier Group. Financial terms of the deal remain undisclosed. Existing shareholder FLOTTE Beteiligungen GmbH will maintain its stake through a reinvestment in the company, located in Münster, Germany. Avista's acquisition underscores its commitment to consumer healthcare and preventative health trends, marking its ninth platform investment in this sector.

sanotact is a producer and distributor of VMS products with a versatile business model combining a scaled contract development and manufacturing organization (CDMO) and a portfolio of proprietary brands, such as sanotact®. The company supports drugstores and distributors in over 80 markets worldwide, offering expertise across various VMS dosage forms. Both Avista and Damier have highlighted the company's manufacturing quality, innovation capabilities, and robust market presence as pivotal factors for potential growth and international expansion.

The acquisition aligns with Avista's strategy to capitalize on growing consumer interest in preventative health. Avista Chairman Thompson Dean emphasized the deal's strategic fit with sanotact's potential to leverage strong secular tailwinds in the consumer health domain. Damier Group's founder, Yvan Vindevogel, reiterated the importance of targeting platforms that align with long-term trends in self-care, underscoring sanotact's ability to tap into Europe's accelerating shift towards self-care.

The transaction signals a broadening of Avista's partnership with the Damier Group, notably with Yvan Vindevogel's family office. Sanotact CEO Martin Spengler expressed enthusiasm for working with the new partners, who bring significant expertise and a track record in fostering strategic expansion and innovation. Meanwhile, Haymo Modelhart, Chairman of FLOTTE Beteiligungen, emphasized the importance of aligning with partners who share a commitment to quality and customer engagement.

Completion of the acquisition remains contingent upon regulatory approvals. As Avista and its partners look to advance sanotact’s market reach, the broader VMS industry could see increased competitive pressures, especially from companies looking to meet the rising global demand for healthcare and wellness products.